[177Lu]FAP-VG-02

N/A

Report date: 2025/11/17 10:28:55

NME

Base Information

Drug Name[177Lu]FAP-VG-02

Drug Alias Name177Lu-FAP-VG-02[177Lu]FAP-VG-02

ClassificationRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radionuclide Drug ConjugatesRadiation-emitting products > Radioactive therapeutic agent

Mechanisms of ActionFibroblast activation protein alpha binders

TargetsProlyl endopeptidase FAP

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesVitsGen Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesVitsGen Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A